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Summary
Human Papillomaviruses (HPV) 16 is a DNA virus encoding three oncogenes – E5, E6, and E7. The
E6 and E7 proteins have well-established roles as inhibitors of tumor suppression, but the contribution
of E5 to malignant transformation is controversial. Using spontaneously immortalized human
keratinocytes (HaCaT cells), we demonstrate that expression of HPV16 E5 is necessary and sufficient
for the formation of bi-nucleated cells, a common characteristic of precancerous cervical lesions.
Expression of E5 from non-carcinogenic HPV6b does not produce bi-nucleate cells. Video
microscopy and biochemical analyses reveal that bi-nucleates arise through cell-cell fusion. Although
most E5-induced bi-nucleates fail to propagate, co-expression of HPV16 E6/E7 enhances the
proliferation of these cells. Expression of HPV16 E6/E7 also increases bi-nucleated cell colony
formation. These findings identify a new role for HPV16 E5 and support a model in which
complementary roles of the HPV16 oncogenes lead to the induction of carcinogenesis.
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Introduction
Prior infection with human papillomavirus (HPV), a small, non-enveloped DNA virus, is
strongly associated with the development of cervical cancer, anogenital cancer, and certain
proliferative disorders (Bosch et al., 2002). Of the approximately 120 types of HPV, thirteen
(HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 66) have been designated as
“carcinogenic” by the International Agency for Research on Cancer (IARC) (Cogliano et al.,
2005). Of these carcinogenic HPVs, HPV16 is the most prevalent and is detected in 57.6% of
cervical cancers (Munoz et al., 2004). Despite the clear association between cervical cancer
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and HPV, the sequence of molecular events that follow HPV infection and lead to cervical cell
transformation remain to be defined.
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The ∼8000 base pair HPV genome is comprised of 8 genes. Three of these, early genes, E5,
E6, and E7 have been shown to be oncogenic. E6 and E7 inhibit the function of the tumor
suppressors p53 and Rb, respectively (Jones, Thompson, and Munger, 1997; Werness, Levine,
and Howley, 1990). Expression of E6 or E7 enables cells to bypass normal cell cycle
checkpoints and allows uncontrolled replication of cervical cells persistently infected with
HPV. This process enables cells to accumulate additional genomic aberrations, but is not
thought to be directly responsible (Incassati, Patel, and McCance, 2006; Plug-DeMaggio et al.,
2004). It has been suggested that the development of genomic instability is secondary to
inhibition of cell cycle checkpoint regulators (Duensing and Munger, 2002).
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The third oncogenic protein of the HPV genome, E5, is sufficient to transform mouse
fibroblasts and keratinocytes in culture, as assessed by anchorage independent growth and
colony formation assays (Leechanachai et al., 1992; Pim, Collins, and Banks, 1992; Straight
et al., 1993). Co-expression of E5 with either E6 or E7 potentiates the transforming properties
of either protein alone (Bouvard et al., 1994; Stoppler et al., 1996; Valle and Banks, 1995).
However, the mechanism by which E5 participates in transformation is unclear. The diverse
functions proposed for E5 include protecting the cell against apoptosis (Kabsch and Alonso,
2002; Zhang, Spandau, and Roman, 2002), interfering with cell-cell communication (Oelze et
al., 1995), and inhibition of antigen presentation in infected cells (Zhang et al., 2003). However,
the most commonly accepted model is that the E5 gene product potentiates the signaling of the
epidermal growth factor receptor (EGFR) by slowing EGFR endocytic trafficking and
degradation (Straight, Herman, and McCance, 1995; Straight et al., 1993; Zhang et al., 2005).
Identifying a molecular role for E5 in infected tissues has been difficult due to its low level of
protein expression, rare integration of the E5 gene into the host chromosome, and a lack of
reagents, antibodies, and animal models (Conrad et al., 1994; Disbrow, Hanover, and Schlegel,
2005; Oelze et al., 1995; Oetke et al., 2000; Straight, Herman, and McCance, 1995). The
scarcity of data due to these technical difficulties has impeded the generation of a definitive
model for E5 function.
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In this report, we examine the effect of HPV16 E5 expression in human keratinocytes, the cell
type transformed in vivo by HPV16. Expression of HPV16 E5 causes the formation of binucleated cells by inducing cell-cell fusion. Normally, intrinsic cell cycle checkpoints prevent
propagation of bi-nucleated cells. However, expression of HPV16 E6/E7 inhibits p53 and Rb,
and thereby facilitates cell proliferation and transformation. These data support a model in
which E5 plays a critical initiating role in the early stages of HPV-induced cellular
transformation.

Results
There are conflicting reports of HPV16 E5 function in the literature. To better understand the
role of HPV16 E5 in the context of the whole virus, we expressed either the genome of wild
type HPV16 (WT HPV16) or HPV16 with a frame shift mutation in the E5 gene (HPV16 E5
fs) in HaCaT cells, a spontaneously immortalized human keratinocyte cell line (Boukamp et
al., 1988). This frameshift mutant only expresses the first 11 amino acids of the protein, and
this E5 fragment is not a functional protein (Genther et al., 2003). There were striking
differences in the cell morphology following expression of WT HPV16 and HPV16 E5 fs
(Figure 1A). Cells expressing WT HPV16 had more than three times the number of bi-nucleated
cells as those expressing HPV16 E5 fs mutation (Figure 1B) despite similar levels of the HPV16
genome being expressed (Figure 1C).
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To better study the function of HPV16 E5, we generated tetracycline-regulatable adenoviruses
that express hemagglutinin (HA) tagged HPV16 E5. The cDNA encoding the HA epitope
allows detection of the exogenous HPV16 E5 since antibodies to HPV16 E5 itself are not
available. To enhance protein expression, codons of the HPV16 E5 cDNA were optimized to
the tRNAs that are prevalent in mammalian cells (Disbrow et al., 2003). The HA epitope was
engineered onto either the 5′ or 3′ end of the HPV16 E5 cDNA and the resulting proteins were
designated as HA-E5 and E5-HA, respectively (Figure 2A). HaCaT cells were stably
transfected with the tetracycline transactivator (tTA-HaCaT) to produce a “tet-off” system
(Gossen and Bujard, 1992). tTA-HaCaT cells were infected separately with each E5-encoding
adenovirus. Infection with either adenovirus resulted in E5 protein expression in ∼90% of cells
by 24 hours post-infection. The addition of tetracycline to infected cells abrogated expression
of the E5 protein (Figure 2B) and served as a control for any potentially deleterious effects of
the adenovirus. This model system allows the examination of the functional consequence of
E5 expression for up to 96 hours (Figure 2C).
Expression of HPV16 E5 increases the percentage of bi-nucleated cells
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Consistent with our observation following expression of the WT HPV16 genome, expression
of HPV16 E5 alone caused an increase in bi-nucleated cells. The number of bi-nucleate cells
increased 3-fold within 72 hours of E5 expression as compared to time-matched controls
(Figure 3). Cells infected with adenovirus in the presence of tetracycline to inhibit HA-E5
expression did not give rise to bi-nucleated cell, nor did cells infected with a β-galactosidase
encoding control adenovirus. Similar increases in bi-nucleation were seen with expression of
HPV16 E5-HA (data not shown).
To ensure that the increases in bi-nucleated cells were not a by-product of adenovirus infection,
we transfected cells with a plasmid encoding HPV16 HA-E5. Bi-nucleate cells were formed
in HaCaT cells following transient transfection with plasmids encoding HA-E5 (pcDNA3HA-E5), but not with the parental plasmid alone (Figure 4).
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To determine whether the increase in the percentage of bi-nucleated cells was specific for
HPV16 E5 or could arise following the expression of E5 from any HPV, we examined the cell
morphology of HaCaT cells following expression of HPV6b E5. HPV6b is a non-carcinogenic
HPV, but its E5 protein contains a similar percentage of hydrophobic amino acids as the E5
from HPV16 (61% and 58%, respectively) (Figure 5A). The HPV6b E5, like the HPV16 E5,
was codon-optimized to enhance protein expression in mammalian cells. When HaCaT cells
were transfected with a plasmid encoding HPV6b E5 (pCDF1-HPV6b-HA-E5), the percentage
of bi-nucleated cells was comparable to cells transfected with empty plasmid (Figure 5B, and
5D), in contrast to HaCaT cells transfected with a plasmid encoding HPV16 HA-E5 (pCDF1HPV16 HA-E5) (Figure 5B and 5D).
HPV16 E5 causes bi-nucleated cells by inducing cell-cell fusion
Cells can become bi-nucleated if they fail cytokinesis or by cell-cell fusion. To determine
whether E5 caused aberrant cytokinesis, we used video microscopy to monitor cells as they
progressed through mitosis. More than 40 cells expressing HPV16 E5 were filmed and all
underwent normal cytokinesis (data not shown). Thus, we concluded that the bi-nucleate cells
induced by E5 do not appear to be a consequence of abortive cytokinesis.
However, during the live cell analysis, we observed HPV16 E5-positive cells undergoing cell
fusion (Supplemental Figure 1). To quantify the percentage of cells that fused, tTA-HaCaT
cells were transfected with a plasmid encoding Red Fluorescent Protein-tagged histone H2B
(pRK7-H2B-RFP). These cells were mixed with untransfected cells in a 1:1 ratio. The mixed
culture was infected with an adenovirus expressing HPV16 E5, and incubated for 24-72 hours.
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At 24-hour intervals, the cells were fixed, permeabilized, and DAPI stained. Bi-nucleate cells
were analyzed by epifluorescent microscopy for the presence of RFP-H2B labeled and
unlabeled nuclei. Bi-nucleate cells that arose due to failed cytokinesis would contain two
labeled or two unlabeled nuclei as shown with cells whose cytokinesis is inhibited by treatment
with cytochalasin D (Figure 6A) (or latrunculin B – data not shown). The presence of
heterokaryons, cells containing multiple, genetically different nuclei, would indicate cell
fusion. As a positive control for cell fusion, we treated labeled and unlabeled cells with
polyethylene glycol (PEG 8000) (Figure 6A). As seen in our video microscopy studies, cells
expressing HPV16 E5 gave rise to heterokaryons, indicating cell fusion had occurred (Figure
6A). At 72 hours, 8.6% of all bi-nucleate cells were heterokaryons (Figure 6B).
The observed percentage of heterokaryons is significantly less than the predicted 1:2:1 ratio
of unlabeled bi-nucleate cells:heterokaryons:labeled bi-nucleate cells. However, data from
cells that were fused by PEG indicated that other factors are likely affecting cell fusion. One
explanation may be the transfection efficency of H2B-RFP. Alternatively, after a cell divides,
the close proximity of the recently formed daughter cells makes them more likely to fuse with
one another. Either event would skew the prediction of a 1:2:1 ratio that is based on the
assumption that each cell has an equal number of neighboring labeled and unlabeled cells.
Importantly, the inhibitors of cytokinesis, latrunculin B (not shown) and cytochalasin D (Figure
6B) produced no heterokaryons.
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As a third independent method of assessing whether cell fusion occurred, we developed a
quantifiable cell fusion assay. Using tTA-HeLa cells, separate populations of cells were
transfected with either a plasmid encoding T7 RNA polymerase (pRK7-T7 RNA polymerase)
or a plasmid encoding yellow fluorescence protein (YFP) driven by a T7 promoter (pT7-YFP).
Only when the cells fuse together is the YFP produced. Using this assay, we are able to monitor
the formation of fused cells over time as well as rapidly quantify the number of YFP-positive
cells by FACS.
In cells that express HPV16 HA-E5, there is an increase in the percentage of YFP positive cells
as well as an increase in the mean fluorescent intensity of those cells (See Supplemental Figure
2). Shown in Figure 6C, there is a 7-fold increase in total YFP production (percentage of YFP
positive cells multiplied by mean fluorescent intensity) as compared to cells that were
uninfected, infected with HPV16 HA-E5 in the presence of tetracycline, or infected with a
control β-galactosidase adenovirus. These experiments corroborate the video microscopy
findings (Supplemental Figure 1) and confirms the observation that HPV16 E5 is a fusogenic
agent. Furthermore, these data establish that the ability of HPV16 E5 to induce cell-cell fusion
is not restricted to HaCaT cells, as HPV16 E5 also induces the fusion of HeLa cells.
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Most bi-nucleated cells fail to propagate
Cell-cell fusion has been proposed as an initiator of carcinogenesis, and is a feature of many
oncogenic viruses (Duelli and Lazebnik, 2007). Models implicating a role for cell-cell fusion
in carcinogenesis suggest that the vast majority of the bi-nucleated cells that arise from cellcell fusion become quiescent or apoptotic. Those that escape cell cycle arrest or cell death and
replicate, have an increased propensity to become aneuploid, presumably because the cell is
not equipped for processing twice the normal number of chromosomes and over time
segregation errors occur. The likelihood of these errors to go undetected is enhanced when cell
cycle checkpoints are disrupted.
To determine if the bi-nucleated cells that formed in response to HPV16 E5 expression acted
in accordance with these models, we monitored cell viability and transformation. Using our
YFP-reporter assay, cells that had undergone cell-cell fusion were collected by FACS, re-plated
in growth media, and were assayed for cell viability by an MTT assay (Figure 7A). In contrast
Virology. Author manuscript; available in PMC 2010 February 5.
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to the parental, mono-nucleated HaCaT cells that grew 3-fold over 72 hours, there was a
reduced viability of bi-nucleated cells. Bi-nucleated cell viability increased slightly if
expression of HPV16 HA-E5 was ablated after cell-cell fusion by the addition of tetracycline.
We inhibited expression of HPV16 E5 because there are numerous reports in the literature that
its expression is transient (Pater and Pater, 1985; Schwartz et al., 1985; Stoler et al., 1992). To
assess the contribution of other HPV16 oncogenes, we co-transfected the cells with p1321
HPV-16 E6/E7, a plasmid that expresses HPV16 E6/E7 from the human β-actin promoter
(Munger et al., 1989). HPV16 E6/E7 impede cell cycle checkpoint inhibitors (p53 and Rb) and
permit propagation of cells that would otherwise be growth arrested. Bi-nucleated cells that no
longer express HPV16 HA-E5, but do express HPV16 E6/E7 had more viable cells than the
original plating density, but this cell growth was not statistically significant.
To determine whether fused cells had an increased propensity to be transformed, we monitored
the ability of cells to form colonies on plastic, a measure of cell transformation (Liu et al.,
2000). Ablation of HPV16 HA-E5 in concert with continual expression of HPV16 E6/E7
produced three times the number of colonies observed with constitutive HPV16 HA-E5
expression (Figure 7B). In the absence of HPV16 E6/E7, colony growth was not affected by
the continual presence of HPV16 HA-E5. Colonies that formed were comprised primarily,
although not exclusively, of mono-nucleated cells (Figure 7C). This indicates that the binucleated phenotype can be lost with cell division.

NIH-PA Author Manuscript

Together, these data provide evidence that while most bi-nucleated cells formed as the result
of HPV16 E5 expression cannot proliferate, the coordinated expression of HPV16 E6/E7
promotes some cells to overcome the barriers of quiescence and/or apoptosis and lead to cell
transformation.

Discussion
Although it is widely held that particular types of HPV are the causative agents of cervical
carcinoma, a major unresolved issue in the molecular etiology of this disease has been the role
and contribution of the virally-encoded E5 protein. In the work reported here, we have
identified a novel function for HPV16 E5 as an inducer of cell fusion. Importantly, we provide
corroborating evidence for how this fusogenic property of E5 cooperates with HPV16-encoded
E6 and E7 to promote the initiation of cell transformation. In addition, we provide a cellular
rationale for how the transient and limited E5 expression observed in patient samples could
promote carcinogenesis.

NIH-PA Author Manuscript

HPV16 E5 forms of bi-nucleated cells that do not form with expression of E5 from the nononcogenic, HPV6b E5. Three independent lines of evidence establish that HPV16 E5 causes
bi-nucleate cell formation by inducing cell-cell fusion. First, live-cell video microscopy reveals
HPV16 E5 expressing cells can fuse and bi-nucleate cell formation did not result from abortive
cytokinesis (Supplementary Figure 1). Second, using a heterokaryon fusion assay in which a
population of cells expressing RFP-H2B was mixed with a population of unlabeled cells, we
observed the presence of bi-nucleate cells containing differentially-labeled nuclei (Figure 6A
and 6B). Third, using a fluorescent reporter assay in which the expression of YFP could only
be detected if a cell transfected with a plasmid encoding T7 RNA polymerase fused with a cell
transfected with a plasmid encoding YFP under the control of the T7 promoter. Only mixed
populations of cells expressing HPV16 E5 produced YFP (Figure 6C). Consistent with all of
this cell fusion data, we also found that bi-nucleated cells were produced with greater than a
3-fold frequency upon introduction of the intact HPV16 genome into HaCaT cells as compared
to cells transfected with an HPV16 genome harboring a mutant E5 gene encoding a truncated,
nonfunctional E5 protein.
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Cell-cell Fusion in Biology and Pathology
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Cell-cell fusion has been reported to occur naturally during a number of developmental
processes (i.e. skeletal and cardiac muscles) (Chen and Olson, 2005). Recently, there has been
increased interest in the role of cell-cell fusion in oncogenesis, particularly fusogenic events
mediated by viruses. Many oncogenic viruses, such as Hepatitis B virus, Hepatitis C virus,
Karposi sarcoma virus, and Epstein-Barr virus, mediate cell-cell fusion and this fusogenic
activity has been posited to be a key initiating event in the development of cancer (Duelli and
Lazebnik, 2007). The fact that the carcinogenic HPV16 encodes a protein that causes cell-cell
fusion is not entirely surprising, although the assignment of this role to E5 is novel. Further,
this finding correlates well with the presence of bi-nucleated cells in pre-cancerous cervical
lesions (Mittal, Chan, and Demopoulos, 1990; Prasad et al., 1993).
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HPV16 E5 has many of the features common to fusogenic proteins. It is a class I integral
membrane proteins with a high degree of hydrophobicity, and can undergo oligermerization
(Gieswein, Sharom, and Wildeman, 2003; Martin and Ryuysschaert, 2000). Hydropathy
profiles of the E5 gene products from all HPVs reveal that the proteins can be phylogenetically
and biochemically divided into four major groups (E5α, β, δ, and γ) (Bravo and Alonso,
2004). The E5 proteins from all 13 carcinogenic HPVs belong to the E5α group that shares the
common structure of three hydrophobic domains. HPV16 E5 is comprised of three hydrophobic
stretches of 15-22 amino acids, although only the first is predicted to be long enough to span
the plasma membrane. In contrast, HPV6b E5 is a member of the E5γ group, and has two longer
hydrophobic stretches (30 and 40 amino acids each). For HPV16 E5, the carboxyl and amino
termini are hydrophilic, and thought not to be associated with the plasma membrane, although
the exact orientation is not known (Nath et al., 2006). Immunofluorescence analysis of nonpermeabilized cells revealed that HPV16 E5 localizes to the plasma membrane1. Given the
data indicating that HPV16 E5 can mediate cell-cell fusion, the three hydrophobic domains
may be a necessary structural feature that confers fusogenic properties to E5s. Consistent with
the idea that there is a structural component to HPV16 E5 mediated cell fusion is the observation
that the comparably hydrophobic, but structurally distinct, HPV6b E5 does not cause cell-cell
fusion.
Role for cell Fusion in HPV-mediated Carcinogenesis
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E5 expression is believed to be transient and limited following the infection of cervical
epithelium by HPV. This notion stems from the kinetics of E5 mRNA levels in tissue samples
and the observation that E5 expression is not observed in malignant cervical tumors (Schwartz
et al., 1985; Stoler et al., 1992). The failure of the HPV16 E5 gene to integrate into the host
cell's genome (Schwartz et al., 1985) suggests sustained expression of E5 is not necessary.
Finally, numerous HPV-positive cell lines fail to generate E5 mRNA at detectable levels (Pater
and Pater, 1985; Schwartz et al., 1985). Of note, E5 mRNA is the best estimate of E5 expression
given the absence of antibodies to detect the protein. These observations coupled to our novel
findings that E5 is a fusogen (Figures 6 and 7) and that sustained E5 expression compromises
cell viability (Figure 7), have led to our model that transient E5 expression favors cellular
transformation whereas sustained E5 expression likely leads to multiple cell fusion events and
cell death (Figure 7). Thus, our data provide the first experimental rationale for transient
expression of E5 that apparently occurs in HPV-infected patients.
Experimental evidence for cell fusion contributing to carcinogenesis comes from a recent paper
by Duelli et al. in which they demonstrate that cell fusion is sufficient to induce chromosomal
instability (Duelli et al., 2007). The authors show that if cell-cell fusion occurs concomitantly
with oncogene expression and cell cycle deregulation, tumor formation can result. The authors
1L. Hu and B. Ceresa, data not shown.
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speculate that if such a fusogenic agent were expressed in the presence of HPV16 E6 and E7,
that could explain how cervical cancer is induced.
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Progression of an HPV-infected cell to a tumor is a rare event that occurs over a long timeframe.
Neoplastic progression is associated with cells containing an abnormal complement of DNA
and a dysregulated cell cycle which enables them to divide despite their detachment from
basement membrane. Progression to fully evolved cancer would require the accumulation of
additional key abnormalities; events that likely occur infrequently. Based on our data and
reports in the literature, we have developed the “hit and run” model for the contribution of E5
to the initiation of tumorigenesis in the context of an HPV infection. The salient features of
this model are: (1) cervical epithelial cells are infected with HPV and the HPV genome is
episomally maintained. (2) The “hit” - E5 mRNA levels peak and expression of the E5 protein
leads to cervical cell-cell fusion and the accumulation of tetraploid and polyploid cells. (3) The
resulting genomic insult triggers the stabilization and activation of p53. (4) The expression of
E5 is downregulated – the “run”. (5) The expression of E6 promotes the ubiquitin-dependent
degradation of p53, thus enabling the cells to overcome the gatekeeper function of p53 which
functions to arrest genomically-compromised cells. (6) Expression of E7 blocks Rb thereby
preventing terminal differentiation of the infected epithelial cells. Collectively then, the
expression of E5, E6, and E7, produces cells that (i) have an abnormal amount of DNA due to
cell-cell fusion, (ii) are defective in cell cycle regulation, and (iii) are no longer properly
programmed to terminally differentiate.
Data presented in Figure 7 support this model. By specifically examining bi-nucleated cells
derived following E5 expression, we were able to assess the interplay of HPV16 E5, E6, and
E7 on cell viability and transformation. Under all conditions, bi-nucleated cells fail to propagate
over the course of 72 hours (Figure 7A), although cell viability was increased by attenuating
expression of HPV16 E5 or increasing expression of HPV16 E6/E7. Although few bi-nucleated
cells form colonies, the likelihood for colony formation increases 3-fold when expression of
HPV16 HA-E5 is temporally regulated and the E6/E7 oncogenes are expressed. Further, the
colonies that arise from these bi-nucleated cells consist mainly of mono-nucleated cells
indicating the bi-nucleated cells can divide when HPV16 E6/E7 are present.
Unlike the other two HPV16 oncogenes, E6 and E7, which cause unregulated cell proliferation,
our findings indicate that E5 induces bi-nucleated cell formation, a characteristic of cervical
cancer. These results support a role for HPV16 E5 inducing bi-nucleated cells that may promote
genomic instability in subsequent rounds of cell division. These data provide the groundwork
for a plausible mechanism by which E5, E6 and E7 work in concert to increase the likelihood
of cellular transformation.
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Materials and Methods
Generation of tTA-HaCaT cells
HaCaT cells were retrovirally infected with the tetracycline transactivator (tTA) (Clontech
Retroviral GeneTransfer and Expression System). Neomycin resistant colonies were grown in
400 μg/ml G418. Individual colonies were isolated, amplified, and screened based on their
ability to regulate expression of tetracycline-regulatable adenovirus. tTA-HeLa cells were
generously obtained from Dr. Sandra Schmid (The Scripps Research Institute).
Parental HaCaT and tTA-HaCaT cells were maintained in Dulbecco's Minimal Essential Media
(DMEM) supplemented with 10% fetal bovine serum (FBS), 100 units/ml penicillin, 100 units/
ml streptomycin, and 2 mM glutamine. tTA-HeLa cells were maintained in the same media
but with 5% FBS. Cells stably transfected with tTA were maintained in 400 μg/ml G418. All
three cell lines were maintained at 37°C in 5% CO2.
Virology. Author manuscript; available in PMC 2010 February 5.
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Adenovirus generation/expression
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Codon optimized HPV16 E5 was generated as previously described (Disbrow et al., 2003). A
hemagglutinin (HA) epitope (MEYDVPDYAH) was engineered to be expressed on either the
amino (HA-E5) or carboxyl (E5-HA) terminus of the protein by PCR, making the appropriate
modification of stop codons. Adenoviruses were generated using Clontech Adeno-X™ Tetoff expression system. All adenoviruses were sequenced at the DNA sequencing facility at the
Oklahoma Medical Research Foundation.
Plasmids and transfection
HA-tagged, codon optimized HPV6 and HPV16 E5 were generated as described above and
subcloned into either the pcDNA3 (Invitrogen) or pCDF1-MCS2-EF2-copGFP (System
Biosciences).
The wild type HPV16 genome and E5 frameshift mutation were cloned into a pUC-18 plasmid
for the replication and antibiotic selection for purification (Genther et al., 2003). Prior to
transfection, CsCl purified cDNA (10 μg) was digested with BamH1 to isolate the HPV16
genome from the backbone plasmid and the result ∼8000 bp DNA fragment was isolated by
gel purification. The HPV16 genome (2 μg) along with GFP-neomycin (pEGFP-C1; Clontech)
was introduced into 2×106 HaCaT cells by nucleofection (Amaxa).
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pRK7-T7 RNA polymerase was generated by using PCR primers to clone T7 RNA polymerase
from BL21 E. coli (primer pairs 5′ TTA CAT TCT AGA ATG AAC ACG ATT AAC ATC
GCT AAG- 3′ and 5′ATG TAA CTC GAG TTA CGC GAA CGC GAA CGC GAA GTC CGA
– 3′). The primers incorporated XbaI and XhoI restriction enzyme sites. The resulting PCR
product was digested with XbaI and XhoI, and ligated into the same sites in pRK7 (with a
multiple cloning site that has been altered to include an XhoI site) such that the gene was driven
by the plasmid's CMV promoter. The T7 promoter driving the expression of His6-S-tagged
Yellow Fluorescent Protein (YFP) in pET30 (Novagen) was amplified using PCR primers that
added Spe1 sites upstream of the T7 promoter and downstream of the t7 terminator. The PCR
product was digested with SpeI, and subcloned into the pRK7 that was digested with SpeI and
XbaI to remove the CMV promoter. The resulting plasmid is referred to as pT7-YFP.
Cell lysates and Immunoblotting
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Cell lysates were prepared as previously described (Dinneen and Ceresa, 2004). Proteins were
resolved on 16% Tris-Tricine gels and transferred to nitrocellulose. Antibodies were obtained
from the indicated sources: anti-HA (12CA5 antibody, Roche), α-tubulin (Sigma), HPV16 E7
(Zymed). Proteins were visualized with enhanced chemiluminescence and documented using
a UV Products Imaging system.
Indirect immunofluorescence
Indirect immunofluorescence was performed as previously described (Dinneen and Ceresa,
2004). The 12CA5 antibody was used at a dilution of 1:1000 and Alexa 488- or Alexa 568conjugated goat anti-mouse (Molecular Probes) was used at a dilution of 1:250. Cells were
also stained with 10 ng/ml DAPI (Sigma). Images were captured using Olympus AX70
epifluorescent microscope with Q-Capture software. Bi-nucleated cells were calculated as the
number of cells with two nuclei divided by the total cells.
Heterokaryon formation assay
tTA-HaCaT cells (2 × 106 cells) were transfected with pRK7-histone 2B-RFP (1.5 μg plasmid)
by nucleofection using the Amaxa Nucleofector I (transfection efficiency ≥50%). After 24
hours recovery, cells were mixed in a 1:1 ratio with untransfected cells and then infected with

Virology. Author manuscript; available in PMC 2010 February 5.

Hu et al.

Page 9

NIH-PA Author Manuscript

HA-E5 adenovirus (20 pfu/cell) or treated with cytocholasin D or latrunculin B. At 24-hour
intervals, cells were fixed and observed by fluorescence microscopy for bi-nucleated cells. As
a positive control, heterokaryons were induced by treatments with polyethylene glycol for 5
minutes (Madan and DeFranco, 1993).
FACS analysis
Cells were fixed in 70% ethanol, and incubated with 20 μg/ml propidium iodide (Sigma) for
one hour at 37°C. Cells were analyzed using a FACS Calibur (Becton Dickinson). The data
from 10,000 cells/experiment were analyzed using Modfit LT 2.0 software (Verity).
Video Microscopy
Time-lapse phase-contrast images were collected using a Zeiss Axiovert 200M microscope
equipped with a Hamanatsu ORCA camera and processed with Metamorph Software
(Molecular Devices) as previously described (Potapova et al., 2006).
Cell Fusion assay
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tTA-HeLa cells were transfected by calcium phosphate with either a plasmid expressing T7
RNA polymerase (pRK7-T7 RNA polymerase) or yellow fluorescent protein (YFP) driven by
a T7 promoter (pT7-YFP). Following 16 hours of recovery, cells were washed, and replated
with 200,000 cells of each population (1:1 ratio) into a well of a 12-well dish. Cells were
infected with adenovirus as indicated in the figure legend using the method described above.
Seventy-two hours post-infection, cells were collected, washed in PBS, and analyzed using a
FACS Calibur (Benton Dickson) at the OUHSC Flow and Imaging Cytometry Laboratory. The
data from >10,000 cells/experiment were analyzed using Modfit LT 2.0 software (Verity). Data
were plotted as the relative increase in the total percentage of YFP (percentage of positive cells
multiplied by their fluorescent mean intensity) as compared to cells without virus infection.
Cell viability and colon formation assays
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Cells were transfected as described for the cell fusion assay or co-transfected with p1321
HPV-16 E6/E7 plasmid (Addgene plasmid 8641) (Munger et al., 1989). Bi-nucleated, fused
cells were isolated by an Influx Cell Sorter at the OUHSC Flow and Imaging Cytometry
Laboratory. For cell viability assays, cells were plated at a density of 2500 cells/well and grown
in growth media with and without tetracycline for 72 hours. As a control, the parental tTAHaCaT cells were plated at the same density. Cell viability was monitored by MTT assay as
previously described (Hansen, Nielsen, and Berg, 1989). Colony formation was measured by
plating cells at a density of 500 bi-nucleated cells/35 mm dish. Cells were maintained in growth
media with and without tetracycline for 21 days (media changed every three days), fixed and
stained with methyl violet (Liu et al., 2000). Only cell clusters of greater than 100 cells were
considered colonies.

Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Expression of the wild type HPV16 genome, but not HPV16 with an E5 frameshift
mutation, causes the formation of bi-nucleated cells

A) HaCaT cells were co-transfected with 2 μg of pEGFP-C1 and 2 μg of linearized WT HPV16
or HPV16 E5 fs by nucleofection. Following recovery of the cells (72 hours), cells were fixed,
stained with DAPI, and examined by fluorescent microscopy. Shown are representative images
of DAPI stained nuclei, GFP-positive (transfected) cells, and the merger of the two images.
Arrow indicates a bi-nucleated cell. Size bar = 10 μm. B) Quantification of the percentage of
bi-nucleated cells (n=3). Data are plotted as the average ± S.E.M. of percentage of bi-nucleated
cells following transfection with nothing, wild type HPV16, or HPV16 with an E5 frameshift
mutation. * indicates p-value < 0.01 (two tailed student's t-test) C). Cell lysates from the
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experiment described in A were collected, resolved by 16% Tris-tricine gel, and immunoblotted
for HPV16 E7 (Zymed).
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Figure 2. Expression of Hemaggluttinin-tagged HPV16 E5 by adenovirus is tetracycline regulatable

A) Hemaggluttinin (HA) tagged HPV16 E5 proteins used in this study. B) Parental HaCaT and
tTA-HaCaT cells were uninfected or infected with the indicated adenoviruses (20 plaque
forming units/cell) in the absence (-) or presence (+) of tetracycline (1 μg/ml). Twenty-fours
hours after infection, cell lysates (30 μg) were resolved on a 16% Tris-tricine gel and
immunoblotted with the 12CA5 (anti-HA) mouse monoclonal antibody. C) tTA-HaCaT cells
were infected with nothing, HA-E5, or E5-HA in the absence (-) or presence (+) of tetracycline
(1 μg/ml). Cells lysates were collected at the indicated times post infection (24, 48, 72, 96
hours) and processed as in (B).
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Figure 3. Expression of HPV16 E5 increases the percentage of bi-nucleate cells

A) tTA-HaCaT cells were infected with nothing or HA-E5 in the absence or presence of
tetracycline (tet) as indicated. Cells were fixed and stained by indirect immunofluorescence
with the 12CA5 mouse monoclonal antibody and nuclei were stained with DAPI. Arrow
indicates a bi-nucleated cell. Images were collected using Olympus AX70 epifluorescent
microscope with Q-Capture software. Size bar is 10 μm. B) The percentage of bi-nucleate cells
treated as in (A). Shown is the average percentage ± S.E.M. of bi-nucleate cells from three
independent experiments (≥500 cells/experiment). * indicates a p-value of <0.05 (two-tailed,
unpaired t-test) as compared to time-matched cells infected in the presence of tetracycline.

Virology. Author manuscript; available in PMC 2010 February 5.

Hu et al.

Page 17

NIH-PA Author Manuscript
NIH-PA Author Manuscript
NIH-PA Author Manuscript

Figure 4. Transfection of cells with HA-E5 causes an increase in the percentage of bi-nucleate cells

A plasmid encoding HA-E5 under the direction of a CMV promoter (pcDNA3-HA-E5) or
empty vector (pcDNA3) was introduced into cells by nucleofection (Amaxa Biosystems,
Gaithersburg, MD). A) Transfected cells were fixed and stained by indirect
immunofluorescence using the 12CA5 antibodies and an Alexa488-labeled goat anti-mouse
secondary antibody. Cell nuclei are labeled with DAPI. Arrow indicates a bi-nucleated cell.
Size bar = 10 μm B). The percentage of HA-E5 transfected cells that are bi-nucleate.
Transfected cells that were fixed and stained as in (A) were scored for bi-nucleation. Data are
plotted as the average ± S.E.M. from 3 experiments from at least 500 cells per experiment. *
p-value <0.05 (two tailed, unpaired t-test) as compared to cells transfected with empty vector.
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Figure 5. Expression of the E5 protein from a non-carcinogenic HPV does not cause an increase in
the percentage of bi-nucleate cells
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A) Single letter amino acid code representation of the sequences of the E5 proteins from HPV16
(Seedorf et al., 1985) and HPV6b (Schwartz et al., 1983). Hydrophobic amino acids are
highlighted in grey. B) Shown are representative micrographs from HaCaT cells transfected
with empty vector (pCDF1-MCS2-EF1-copGFP – subsequently referred to as pCDF1), the
HA-tagged HPV6b E5, or HA-tagged HPV16 E5. After transfection (48 hours), the cells were
fixed, subjected to indirect immunofluorescence using the 12CA5 (anti-HA) antibody and
Alexa568-goat anti-mouse secondary antibody (red) to indicate the presence of the HA-tagged
E5 protein. Nuclei were stained with DAPI (blue). Cells transfected with empty vector are
green, indicating the expression of the pCDF1 associated green fluorescent protein (GFP).
Arrow indicates a bi-nucleated cell. Size bar = 10 μm. C) Cells were transfected as in (B). Cell
lysates were prepared and quantitatively immunoprecipitated using the 12CA5 antibody.
Immunoprecipitates were resolved by SDS-PAGE and immunoblotted with the 12CA5. Total
starting materials was probed with an anti-α-tubulin antibody (Sigma) to indicate amounts of
starting material. D) The percentage of bi-nucleated cells was calculated from cells transfected
as in (B). The average percentage of bi-nucleate cells ± S.E.M. from >200 cells/experiment is
plotted (n =3). N.S. indicates the data are not significantly different compared to vector control.
* indicates a p value <0.01 compared to vector control (two-tailed, unpaired t-test).
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Figure 6. Expression of HPV16 E5 causes cell fusion

A) Equal numbers of tTA-HaCaT cells were transfected by nucleofection (Amaxa Biosystems)
with either nothing or pRK7-histone2B-RFP and mixed together at a 1:1 ratio. After recovery
(24 hours), cells were either infected with HA-E5 adenovirus or incubated with 50%
polyethylene glycol (PEG 8000) or 0.6 μg/ml cytochalasin D. After incubation (5 minutes for
PEG treatment, 48 hours for HA-E5 and cytochalasin D), cells were fixed, and stained with
DAPI. Bi-nucleated cells were analyzed by fluorescent microscopy for the presence of
heterokaryons. Shown are representative images of bi-nucleate cells indicating the fusion of
two different cell populations in HA-E5 expressing cells and PEG treated cells. A failure of
cytokinesis was induced by treatment with cytochalasin D. All resulting bi-nucleated cells had
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similarly labeled nuclei. Size bar = 10 μm. B) Graphical representation of the percentage of
hetrokaryons in the population of bi-nucleate cells (n=2-3). The number of heterokaryons per
total bi-nucleated cells is indicated parenthetically in each bar. C) tTA-HeLa cells were
transfected with either pRK7-T7 RNA polymerase or YFP under the control of the T7 promoter
(pT7-YFP), co-plated, infected with HPV16 HA-E5 adenovirus, incubated for 72 hours, and
analysed for the presence of YFP by FACS (see Materials and Methods for details). Data
indicate the fold increase in fluorescence intensity of the YFP-positive cells (calculated from
the percentage of YFP positive cells multiplied by the mean fluorescent intensity) as compared
to the ‘No virus’ control. Shown are the mean ± S.E.M. (n=3-5). * = p < 0.05 (two-tailed,
unpaired t-test). Representative FACS data are shown in Supplemental Figure 2.
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Figure 7. Bi-nucleated cells have increased colony formation in the presence of HPV16 E6/E7
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tTA-HaCaT cells were transfected with pRK7-T7 RNA polymerase or pT7-YFP, mixed in a
1:1 ratio, and infected with HPV16 HA-E5 adenovirus. Some cells were co-transfected with
p1321 HPV-16 E6/E7 (+E6/E7). After infection (72 hours), YFP-positive, bi-nucleated cells
were collected by FACS and plated for MTT assay, colony formation assay, or cultured to
collect cell lysate. Parental, mononucleated tTA-HaCaT cells were plated in parallel. To sustain
HPV16 HA-E5 expression (indicated by “yes”), cells were growth without tetracycline; to
abrogate HPV16 HA-E5 expression (indicated by “no”), cells were grown with tetracycline.
A) Cells were plated at 2500 cells/well of a 96-well dish (plating density is indicated with solid
line) and grown for 72 hours in growth media. Cell viability was measured by MTT assay.
Data are plotted as the average number of cells/well (n=4). * indicates p <0.05 in paired
student's t-test. B) Cells were plated at 500 cells/well of 6 well dish (6 wells/condition in each
assay). Cells were grown for 21 days with media changes every 3 days. Colonies were stained
with methyl violet. Only colonies visible to the naked eye were counted (colonies contained
>100 cells/colony). Data are normalized to growth without tetracycline for each transfection
condition. (n=6). * indicates p<0.01 using chi square analysis. C) Representative images of a
colony at 4× and 10× magnification (size bar = 100μm). D) Parallel dishes of cells were grown
with and without tetracycline for 72 hours. Cell lysates were prepared, resolved on a 16% Tristricine gel, and immunoblotted for either HA-E5 (12CA5 antibody) or HPV16 E7. Since
HPV16 E6 and E7 are driven by the same promoter on the same plasmid, expression of HPV16
E7 was interpreted as expression of both HPV16 E6 and E7.
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